Literature DB >> 9344401

Current concepts in the pathogenesis of Alzheimer's disease.

D B Carr1, A Goate, D Phil, J C Morris.   

Abstract

Alzheimer's disease (AD) affects a large proportion of the increasingly aging population of this country, with prevalence rates as high as 47% for those >85 years old and a total annual cost approaching $70 billion. There is no currently validated test for detection of dementia of the Alzheimer type (DAT). Because of this and the insidious onset of the disease, the diagnosis may be missed by primary care physicians. Cerebral extracellular beta-amyloid deposition as senile plaques and intraneuronal neurofibrillary tangles appear to represent critical processes in the development of AD; however, whether and the extent to which these may also occur in nondemented aging is uncertain. Tangles occur primarily in medial temporal lobe structures (hippocampus, entorhinal cortex, and amygdala), and tangle density correlates with dementia severity. Plaques are diffusely distributed throughout the cerebral cortex, and are the neuropathologic hallmark of the disease. Aging is the primary risk factor for AD. After controlling for differential life expectancy, female sex still appears to be an additional risk factor. There may be a genetic component, in some cases based on family and twin studies. Allelic variation in the apolipoprotein E (Apo E) gene located on chromosome 19 represents another important risk factor. However, the diversity of gene mutations apparently responsible for the various forms of AD suggest that the disease is genetically heterogeneous. AD may be conceptualized as an imbalance between neuronal injury and repair. Oxygen free radicals may be involved in the cross-linking process of beta-amyloid aggregation, and antioxidants may represent a potential intervention. There may be a role for heavy metals in the pathogenesis of AD, but this remains controversial. Work continues toward possibly a cure or prevention, but more likely palliation, of AD, and the results of trials of anti-inflammatory agents, estrogen, and antioxidant therapy are anticipated in the near future.

Entities:  

Mesh:

Year:  1997        PMID: 9344401     DOI: 10.1016/s0002-9343(97)00262-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  21 in total

1.  Effects of active constituents of Crocus sativus L., crocin on streptozocin-induced model of sporadic Alzheimer's disease in male rats.

Authors:  Mohsen Khalili; Faezeh Hamzeh
Journal:  Iran Biomed J       Date:  2010 Jan-Apr

2.  Galantamine: a pharmacoeconomic review of its use in Alzheimer's disease.

Authors:  Katherine A Lyseng-Williamson; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 3.  Galantamine: a review of its use in Alzheimer's disease.

Authors:  L J Scott; K L Goa
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

4.  Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways.

Authors:  Libang Yang; Kristina Lindholm; Yoshihiro Konishi; Rena Li; Yong Shen
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

5.  Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer's Disease.

Authors:  Evan E Hubbard; Lilian R Heil; Gennifer E Merrihew; Jasmeer P Chhatwal; Martin R Farlow; Catriona A McLean; Bernardino Ghetti; Kathy L Newell; Matthew P Frosch; Randall J Bateman; Eric B Larson; C Dirk Keene; Richard J Perrin; Thomas J Montine; Michael J MacCoss; Ryan R Julian
Journal:  J Proteome Res       Date:  2021-11-24       Impact factor: 4.466

Review 6.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

Review 7.  The pleiotropic effects of HMG-CoA reductase inhibitors: their role in osteoporosis and dementia.

Authors:  Alla Waldman; Leonard Kritharides
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Clinical field-strength MRI of amyloid plaques induced by low-level cholesterol feeding in rabbits.

Authors:  John A Ronald; Yuanxin Chen; Lisa Bernas; Hagen H Kitzler; Kem A Rogers; Robert A Hegele; Brian K Rutt
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

Review 9.  Economic considerations in the management of Alzheimer's disease.

Authors:  Carolyn W Zhu; Mary Sano
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

Review 10.  Role of Withaferin A and Its Derivatives in the Management of Alzheimer's Disease: Recent Trends and Future Perspectives.

Authors:  Rajib Das; Abdur Rauf; Saima Akhter; Mohammad Nazmul Islam; Talha Bin Emran; Saikat Mitra; Ishaq N Khan; Mohammad S Mubarak
Journal:  Molecules       Date:  2021-06-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.